KR101968754B1 - 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법 - Google Patents
두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법 Download PDFInfo
- Publication number
- KR101968754B1 KR101968754B1 KR1020170033369A KR20170033369A KR101968754B1 KR 101968754 B1 KR101968754 B1 KR 101968754B1 KR 1020170033369 A KR1020170033369 A KR 1020170033369A KR 20170033369 A KR20170033369 A KR 20170033369A KR 101968754 B1 KR101968754 B1 KR 101968754B1
- Authority
- KR
- South Korea
- Prior art keywords
- dutasteride
- weight
- probe
- hard capsule
- moiety
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20160031468 | 2016-03-16 | ||
KR1020160031468 | 2016-03-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170107933A KR20170107933A (ko) | 2017-09-26 |
KR101968754B1 true KR101968754B1 (ko) | 2019-04-12 |
Family
ID=59850978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170033369A KR101968754B1 (ko) | 2016-03-16 | 2017-03-16 | 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법 |
Country Status (8)
Country | Link |
---|---|
KR (1) | KR101968754B1 (ru) |
CN (1) | CN109152743B (ru) |
AU (1) | AU2017233134A1 (ru) |
BR (1) | BR112018068686A2 (ru) |
EA (1) | EA201891843A1 (ru) |
MX (1) | MX2018011208A (ru) |
PH (1) | PH12018501985A1 (ru) |
WO (1) | WO2017160106A2 (ru) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006055659A2 (en) * | 2004-11-15 | 2006-05-26 | Smithkline Beecham Corporation | Fixed dose combination op dutasteride and tamsulosin |
KR101590072B1 (ko) * | 2014-12-23 | 2016-01-29 | 한미약품 주식회사 | 두타스테라이드를 포함하는 자가유화 약물전달 시스템용 조성물 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW369521B (en) | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
UA80393C2 (ru) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтическая композиция, которая содержит ингибитор фдэ 4, диспергированный в матрице |
ES2287613T3 (es) * | 2004-07-14 | 2007-12-16 | Siegfried Generics International Ag | Granulado para la liberacion controlada de tamsulosina, que contiene alginato. |
CN102247379A (zh) * | 2011-01-12 | 2011-11-23 | 北京润德康医药技术有限公司 | 一种复方制剂及其制备方法 |
CN102145007B (zh) * | 2011-03-03 | 2013-03-20 | 王致中 | 一种非那雄胺软胶囊与盐酸坦索罗辛胶囊复方制剂、所用胶囊及制备方法 |
WO2014002015A1 (en) * | 2012-06-25 | 2014-01-03 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising dutasteride |
EP2976068B1 (en) * | 2013-03-19 | 2018-05-30 | Galenicum Health S.L. | Pharmaceutical compositions comprising an active agent |
CN105073100A (zh) * | 2013-06-21 | 2015-11-18 | 沃克哈特有限公司 | 坦索罗辛或其盐的药物组合物 |
EP2949319A1 (en) * | 2014-05-26 | 2015-12-02 | Galenicum Health S.L. | Pharmaceutical compositions comprising an active agent |
-
2017
- 2017-03-16 BR BR112018068686A patent/BR112018068686A2/pt not_active Application Discontinuation
- 2017-03-16 AU AU2017233134A patent/AU2017233134A1/en not_active Abandoned
- 2017-03-16 KR KR1020170033369A patent/KR101968754B1/ko active IP Right Grant
- 2017-03-16 CN CN201780029107.0A patent/CN109152743B/zh active Active
- 2017-03-16 WO PCT/KR2017/002862 patent/WO2017160106A2/ko active Application Filing
- 2017-03-16 EA EA201891843A patent/EA201891843A1/ru unknown
- 2017-03-16 MX MX2018011208A patent/MX2018011208A/es unknown
-
2018
- 2018-09-14 PH PH12018501985A patent/PH12018501985A1/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006055659A2 (en) * | 2004-11-15 | 2006-05-26 | Smithkline Beecham Corporation | Fixed dose combination op dutasteride and tamsulosin |
KR101590072B1 (ko) * | 2014-12-23 | 2016-01-29 | 한미약품 주식회사 | 두타스테라이드를 포함하는 자가유화 약물전달 시스템용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
WO2017160106A2 (ko) | 2017-09-21 |
MX2018011208A (es) | 2019-05-30 |
CN109152743B (zh) | 2022-01-07 |
BR112018068686A2 (pt) | 2019-01-15 |
AU2017233134A1 (en) | 2018-10-04 |
PH12018501985A1 (en) | 2019-07-08 |
EA201891843A1 (ru) | 2019-04-30 |
KR20170107933A (ko) | 2017-09-26 |
CN109152743A (zh) | 2019-01-04 |
WO2017160106A3 (ko) | 2018-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7394974B2 (ja) | 酢酸アビラテロンを含む医薬組成物、並びにその製造方法及び使用 | |
JP3375960B2 (ja) | 制御放出オキシコドン組成物 | |
KR102286501B1 (ko) | 레날리도마이드의 경구용 정제 조성물 | |
KR20100126465A (ko) | 미코페놀레이트를 포함하는 변형 방출 제약 조성물 및 그것의 방법 | |
EP2906202A1 (en) | Oral drug delivery formulations | |
BR112012028035B1 (pt) | formulação de liberação imediata | |
JP2018035171A (ja) | 医薬製剤 | |
AU2014299447B2 (en) | Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin | |
KR20070119700A (ko) | 페노피브레이트 및 계면 활성제 혼합물을 함유하는 제제 | |
JP2009527477A (ja) | 低紅潮ナイアシン製剤 | |
ES2772137T3 (es) | Preparación de composite que comprende una capa de recubrimiento pelicular que contiene principio activo | |
US20110274753A1 (en) | Dual release oral tablet compositions of dexlansoprazole | |
JP2020500864A (ja) | 経口トリデカン酸テストステロン療法 | |
JP2020503269A (ja) | 経口ウンデカン酸テストステロン療法 | |
JP2020532517A (ja) | 高濃度プリドピジン製剤 | |
KR100798730B1 (ko) | 록소프로펜 또는 잘토프로펜 함유 제어방출성 제제 및 그의제조방법 | |
CN109890372B (zh) | 含埃索美拉唑的复合胶囊及其制备方法 | |
WO2023241688A1 (zh) | 一种用于治疗抗凝血的药物组合物及应用 | |
JP2023071921A (ja) | 様々な用量のレナリドミドの経口用錠剤組成物 | |
KR101968754B1 (ko) | 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법 | |
JP2022514569A (ja) | 非晶質スパルセンタン組成物 | |
WO2014002015A1 (en) | Pharmaceutical composition comprising dutasteride | |
KR101499867B1 (ko) | 활성 성분 (i) 함유 조성물 및 이의 제조 방법 | |
WO2014003371A1 (ko) | 아세브로필린을 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물 | |
US10960001B2 (en) | Opioid agonist / antagonist combination dosage forms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |